Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis by Ping Li et al.
Li et al. Radiation Oncology 2013, 8:155
http://www.ro-journal.com/content/8/1/155RESEARCH Open AccessCorrelation of dynamic changes in γ-H2AX
expression in peripheral blood lymphocytes
from head and neck cancer patients with
radiation-induced oral mucositis
Ping Li†, Cheng-run Du†, Wen-cai Xu, Ze-liang Shi, Qing Zhang, Zhao-bin Li and Shen Fu*Abstract
Background: To evaluate the role of γ-H2AX in peripheral blood lymphocytes (PBLs) as a predictive biomarker of
the severity of oral mucositis (OM) in head and neck cancer (HNC) patients with receiving radiotherapy.
Methods: In vitro assays for evaluating DNA damage and repair kinetics were performed on blood samples
withdrawn from 25 HNC patients undergoing radiotherapy or chemoradiotherapy before radiotherapy. As for the
in vivo study, blood samples were also withdrawn before radiotherapy, and 1 hour after radiotherapy on the fourth
and last days. Flow cytometry was used to assess the expression of γ-H2AX in PBLs. OM was assessed using the
World Health Organization (WHO) scores twice a week and correlated with the expression of γ-H2AX.
Results: The in vitro assay results showed that patients with severe OM had higher γ-H2AX-specific relative
fluorescence at various irradiation doses in the damage kinetics assay, with significantly higher γ-H2AX expression at
8 Gy (p = 0.039), and also at 24 hours after irradiation at a dose of 2 Gy in the repair kinetics assay, compared to the
patients with mild OM (p = 0.008). The optimal cutoff value for relative fluorescence of γ-H2AX was 0.960, 24 hours
post-irradiation. However, there were no significant differences in γ-H2AX expression at different times between the
two groups, as assessed with the in vivo assay.
Conclusions: These results suggest that the damage and repair kinetics of γ-H2AX from PBLs in the in vitro study
may have predictive value for identifying the grades of OM among HNC patients prior to radiotherapy.
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Radiotherapy is one of the main therapies used for treat-
ment of head and neck cancer (HNC). However, even with
highly-refined treatment planning, such as intensity-
modulated radiation therapy, radiation-induced toxicities
in tumor-adjacent normal tissues remain the major limit-
ing factor for the treatment [1]. Oral mucositis (OM) is
one of the most common and severe acute normal tissue
toxicities for HNC patients treated with radiotherapy [2].
OM is associated with considerable pain, dysphagia, and
dysgeusia, resulting in the impairment of the quality of* Correspondence: fushen1117@gmail.com
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reproduction in any medium, provided the orlife. Furthermore, OM is a dose-limiting toxicity and can
lead to treatment interruption, consequentially compro-
mising the likelihood of cure [3]. There are many factors,
including radiation fractionation, dose per fraction, and
irradiated volume, that are associated with OM; even if
nearly identical irradiation schemes are administered in
the clinic, there are inter-individual heterogeneities in OM
among HNC patients [4]. Therefore, an assay that enables
the prediction of the grades of OM before commencing
radiotherapy is highly desirable. Such predictive assays
may help differentiate radiosensitive individuals from
others and allow the treating physicians to modify the
treatment strategies for individual patients to prevent the
occurrence of severe side effects [5,6].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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repair have been considered to be the most relevant in-
dicators of irradiation-associated toxicity to normal tis-
sue [7]. A key factor in the repair process of damaged
DNA is the histone protein H2AX, which is rapidly
phosphorylated at sites of DNA double strand breaks
(DSBs) and can be visualized using immunofluorescence
within a few minutes of exposure of cells to DNA-
damaging agents [8]. Therefore, H2AX levels have been
used to quantitate the ability of cells to damage and
repair DNA after irradiation [9]. The correlation of
γ-H2AX with DNA damage in peripheral blood lympho-
cytes (PBLs), blood mononuclear cells, skin, or other
human tissues has been observed [10]. However, studies
of the association between the expression of γ-H2AX
and the risk of normal tissue toxicities have not yielded
conclusive results [11,12]. A study by Rube et al. [13] indi-
cated that γ-H2AX of lymphocytes from children with solid
tumors could be used to identify DSB-repair deficiencies in
patients who developed severe toxicities to normal tissue
after chemo/radiotherapy. Another study [14] also identi-
fied patients who experienced severe atypical toxicities fol-
lowing radiotherapy based on γ-H2AX expression analysis.
However, no correlation was found by Werbrouck et al.
[15] between the kinetics of the appearance of γ-H2AX foci
and the severity of acute normal tissue reactions.
In this study, we measured the expression of γ-H2AX
using flow cytometry in PBLs using both in vitro and
in vivo assays, and investigated the pattern and kinetics
of the appearance of γ-H2AX foci as predictive markers
for the severity of OM in HNC patients treated with
radiotherapy.
Methods
Patients and clinical conditions
Between November 2011 to June 2012, 31 patients with
HNC treated at the Sixth People’s Hospital of Jiao Tong
University were considered for enrollment in this study.
The study was approved by the local ethics committee,
and all patients provided written informed consent. Four
patients were excluded from the study due to treatment
interruptions. Two patients, who received X-ray examin-
ation or scintigraphy within 48 hours before collection
of the first blood samples, were also excluded. The pa-
tients were irradiated with a 6MV X-ray linear acceler-
ator (Artiste™ Solutions; Siemens, Germany). The mean
dose of radiation was (66.2 ± 8.1) Gy, at 2 Gy per day ad-
ministered 5 days per week. During radiotherapy, all pa-
tients received basic oral care.
Assessment of OM
OM assessments were performed by a specially-trained
radiation oncologist twice a week. Evaluation of OM
was based on the World Health Organization (WHO)classification (1 = soreness and erythema; 2 = ulcers, can eat
solids; 3 = ulcers, requires liquid diet; 4 = ulcers, can not tol-
erate solid or liquid diet). The maximum toxicity score was
used for this study. The dose-volume histogram (DVH) of
oral mucosa was extracted for each patient. The entirety of
the pharyngeal constrictor and oral cavity, which is consid-
ered to play an important role in the development of acute
OM, was considered as “mucosa”. Contours of the oral cav-
ity and the muscular structures of the swallowing were as-
sessed based on previous reports [16,17].
Isolation of PBLs
A 10-mL sample of peripheral venous blood was with-
drawn from patients and placed into EDTA vacutainers.
PBLs were isolated using lymphoprep™ (AXIS-SHIELD
PoC AS, Oslo, Norway) according to the manufacturer’s
instructions. Briefly, whole blood was diluted with an
equal volume of phosphate-buffered saline (PBS), then the
20-mL of diluted blood samples were carefully layered
onto 10 mL of lymphoprep™ and centrifuged at 800 × g for
20 minutes. Then, lymphocytes from the interphase were
isolated and incubated at 37°C in a humidified atmosphere
containing 5% CO2.
For the in vivo assay, blood samples were obtained
from patients before radiotherapy (T0), 1 hour after the
fourth fraction of radiotherapy (T1), and after the last
fraction of radiotherapy (T2).
Blood samples obtained before radiotherapy were used
for the in vitro assay. The lymphocytes were separated
and divided for different experiments. For the damage
kinetics assay, lymphocytes were irradiated at doses of
0, 2, 4, 6, and 8 Gy; for the repair kinetics assay, the cells
was irradiated at a dose of 2 Gy and γ-H2AX expression
was examined at 0, 0.5, 4, and 24 h post-irradiation.
γ-H2AX expression assay
The lymphocytes were fixed in 4% paraformaldehyde for
10 min and permeabilized in a 0.1% solution of Triton
X-100 in PBS for 10 min. Subsequent detection of
γ-H2AX expression was performed after blocking in 5%
fetal bovine serum (FBS) for 30 min at room tem-
perature, using a 1:1000 dilution of the flourescein iso-
thiocyanate (FITC)-labeled mouse monoclonal antibody
against γ-H2AX (Millipore). Following incubation with
the primary antibody for 2 hours, the lymphocytes were
analyzed by fluorescence-activated cell sorting (FACS)
using flow cytometry and the Kaluza software package
(Beckman Coulter). The fluorescence intensity in the cells
post-irradiation was compared to that in untreated control
cells to provide a measure of the relative fluorescence.
Statistical analysis
Statistical analysis was performed using SPSS 13.0 soft-
ware. The effect of gender, treatment regimen, tumor
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the χ2-square test; the independent t- test was used for
analysis of continuous data. The relationship between
the irradiation dose and relative fluorescence of γ-H2AX
in PBLs was examined by linear regression analysis. Dif-
ferences were considered significant when the p-value
was less than 0.05. Receiver Operating Characteristic
(ROC) analysis was performed and the cutoff value was
determined based on the Youden index [18], and the
corresponding sensitivity, specificity, and positive and
negative predictive values were calculated.Results
Clinical characteristics
The clinical characteristics of the patients are shown in
Table 1. There were no differences in the clinical param-
eters between the mild and severe OM groups. Of the
25 patients, 15 patients had mild OM and were classified
as grade 1–2, while 10 patients had severe OM and were
classified as grade 3–4. The percentages for patients ex-
periencing grade 1, 2, 3, and 4 OM were 12.0%, 48.0%,
32.0%, and 8.0%, respectively.Table 1 Clinical characteristics of the patients
WHO mucostis grade p
valueGrade 1–2 Grade 3–4
n (%) n (%)
Age
Mean 51.1 46.2 0.328
Range 28-80 32-67
Gender
Male 8 (53.3%) 6 (60.0%) 1.000
Female 7 (46.7%) 4 (40.0%)
Treatment regime
Radiotherapy 5 (33.3%) 2 (20.0%) 0.659
Chemoradiotherapy 10 (66.7%) 8 (80.0%)
Tumor staging
T1 1 (13.3%) 1 (10.0%) 0.737
T2 5 (33.3%) 5 (50.0%)
T3 3 (20.0%) 3 (30.0%)
T4 2 (13.3%) 1 (10.0%)
Tx 4 (20.0%) 0 (0.0%)
Tumor types
Nasopharyngeal carcinoma 9 (60.0%) 10 (100%) 0.330
Nasal cavity NHL 2 (13.3%) 0 (0.0%)
Nasal cavity carcinoma 2 (13.3%) 0 (0.0%)
Parotid gland carcinoma 1 (6.7%) 0 (0.0%)
External auditory canal carcinoma 1 (6.7%) 0 (0.0%)Relationship between the dose-distribution parameters of
oral mucosa and OM
The correlation between the grades of radiation-induced
OM and DVH data were analyzed (Table 2). From the
DVHs of oral mucosa, mean dose (Dmean), maximal dose
(Dmax), the percentage of mucosa in the contoured re-
gions that received a dose equal to or higher than 15 Gy
(V15), 30 Gy (V30), 40 Gy (V40), 50 Gy (V50), and 60 Gy
(V60) were calculated. None of dose-distribution param-
eters of oral mucosa showed significant differences be-
tween patients with mild or severe OM (p >0.05).Assessment of damage kinetics using γ-H2AX expression
analysis in vitro
After irradiation of PBLs, the fluorescence of γ-H2AX
increased with the irradiation dose (Figure 1). There was
a strong linear correlation between the relative fluorescence
of γ-H2AX in PBLs and the irradiation dose in the pa-
tients with severe (r = 0.998; p = 0.000) and mild (r = 0.976;
p = 0.005) OM. The relative fluorescence of γ-H2AX in
patients with severe OM was higher than that in patients
with mild OM at each irradiation dose, and was particularly
high at the irradiation dose of 8 Gy (p = 0.039).Assessment of repair kinetics using in vitro γ-H2AX
expression analysis
As shown in Figure 2, the relative fluorescence intensity
reached the maximum level at about 0.5 h after irradi-
ation and decreased thereafter. At 24 hours, the relative
fluorescence returned to levels comparable to that of
un-irradiated PBLs in mild OM patients (Figure 2a), but
not in patients with severe OM, indicating a slower rate
of DNA repair in patients with severe OM (Figure 2b).
Furthermore, there was a significantly higher retention
of fluorescence at 24 hours post-irradiation in PBLs
from the severe OM group, compared to the residual
fluorescence in the mild OM group (p = 0.008) (Figure 2c),
while no difference was observed at 0.5 and 4 hours post-
irradiation (Figure 2c). These results suggest that higher
residual DNA damage is present in patients with severe
OM 24 hours after irradiation.Table 2 dose-distribution parameters of oral mucosa
Patients with mild
OM (Mean ± SD)
Patients with severe
OM (Mean ± SD)
p value
Dmean (4102 ± 1183) cGy (4620 ± 232) cGy 0.119
Dmax (6697 ± 608) cGy (7082 ± 293) cGy 0.076
V15 (90.85 ± 21.97)% (99.45 ± 0.79)% 0.152
V30 (74.57 ± 26.74)% (88.14 ± 3.79)% 0.072
V40 (57.45 ± 27.36)% (69.48 ± 7.05)% 0.123
V50 (34.60 ± 19.66)% (39.45 ± 9.28)% 0.417





























Figure 1 Relationship of the applied dose of irradiation and the relative fluorescence of γ-H2AX. Peripheral blood lymphocytes (PBLs)
from patients with severe (grey bard) and mild (white bars) oral mucositis (OM) were irradiated at 0, 2, 4, 6, and 8 Gy. At 1 hour after in vitro
irradiation, the γ-H2AX-associated fluorescence intensity in the lymphocytes was assessed using a FACS-based assay. The γ-H2AX-associated
fluorescence is expressed relative to that of untreated control PBLs. The values shown are the mean ± SD; *p < 0.05.
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To estimate the sensitivity and specificity of the relative
fluorescence of γ-H2AX at 24 hours post-irradiation for
prediction of OM during radiotherapy, ROC analysis
was performed. The optimal cutoff value of residual
γ-H2AX level 24 hours post-irradiation was determined
from the ROC analysis (Figure 3). When a relative fluor-
escence of 0.960 was used as the cutoff value, the sensi-
tivity and specificity of the γ-H2AX fluorescence in
predicting OM were 100% and 53.3%, respectively, and
positive and negative predictive values were 62.5% and
100%, respectively. The area under the curve (AUC) was
0.800 (standard error [SE], 0.094; 95% confidence inter-
val [CI], 0.593–0.931; p = 0.002).
The dynamic change of γ-H2AX expression using the
in vivo assay
To determine the correlation between the kinetic pat-
terns of DNA damage and repair, as assessed using the
γ-H2AX-specific fluorescence with the in vitro assay,
and OM, the relative fluorescence of γ-H2AX was esti-
mated in 15 patients with mild OM and 10 patients with
severe OM at different time points during radiotherapy
(Figure 4). Higher γ-H2AX levels were observed at the
later time points of radiotherapy (p <0.05), but the in-
crease in γ-H2AX expression was not statistically differ-
ent between the two groups of patients at the three time
points during radiotherapy (Figure 4, p <0.05).
Discussion
Development of severe radiation-induced OM during ra-
diotherapy for patients with HNC results in treatment in-
terruptions, hospitalization, and increased cost. Screening
tests that can identify the patients at higher risk for devel-
oping severe OM would enable clinicians to individualize
radiotherapy protocols.The appearance of γ-H2AX foci in PBLs was found to
be closely correlated with DNA DSBs after exposure to
irradiation [6], and more rapid loss of γ-H2AX foci in
human cell lines has been correlated with improved repair
of DNA DSBs [10]. In the present study, flow cytometric
analysis of γ-H2AX induction and removal was used to
predict acute radiation-induced OM in HNC patients.
The extent and kinetics of γ-H2AX expression levels were
measured after in vitro irradiation of patient-derived PBLs,
and the results of the in vitro assays were also compared
with those of the in vivo analysis.
We found a strong linear correlation between the rela-
tive fluorescence of γ-H2AX in PBLs and irradiation
dose in the patients with severe and mild OM, indicating
that γ-H2AX might be useful as a biological marker of
dosimetry after ionizing radiation exposure, which cor-
roborates results in previous reports [19,20]. On the other
hand, our data showed that the dose per fractionation
might be a key parameter that can be applied to estimate
the role of the induction of γ-H2AX in predicting OM
in HNC patients. In the present study, the induction of
γ-H2AX by high-dose irradiation (8 Gy), but not other
lower doses of irradiation (2, 4, or 6 Gy), was significantly
different between the patients with severe and mild OM.
These data suggest that the lack of support for a predictive
role for γ-H2AX in OM reported previously may be due
to the lower doses of irradiation used in prior study [15].
Werbrouck et al. [15] measured the number of γ-H2AX
foci in T-lymphocytes isolated from HNC patients after
in vitro irradiation at 0.5 Gy and were unable to predict
the development of acute normal tissue complications.
An irradiation dose of 2 Gy was used in the study by
Vasireddy et al. [21], which suggested that the formation
of γ-H2AX foci was not significantly different between
patients with severe and mild OM. Taken together, our
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Figure 2 The time-dependent accumulation of irradiation-induced γ-H2AX in PBLs in vitro. The γ-H2AX fluorescence was measured using a
FACS-based assay in PBLs isolated from 15 patients mild OM (a) and 10 patients with severe OM (b) at 0, 0.5, 4, and 24 hours after in vitro exposure to
2 Gy of X-ray radiation. (c) The mean level of the relative fluorescence for patients with severe OM (diamonds) and mild OM (squares); *p <0.05.
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and the higher single dose might be necessary in in vitro
assays to evaluate the correlation between γ-H2AX induc-
tion and OM in the clinical setting.
The results of the repair kinetics assay showed that
lymphocytes had a higher residual level of fluorescence of
γ-H2AX at 24 h, but not at earlier times ( 0, 0.5, and 4 h),
after irradiation with 2 Gy in patients with severe OM,
compared with patients with mild OM. Our observations
are consistent with those of other studies; Bourton et al.
[14] examined γ-H2AX induction and depletion in 12 pa-
tients with acute or late normal tissue toxicity using the
same technique used in this study and found elevated
levels of γ-H2AX fluorescence at 24 h post-irradiation in
patients with severe toxicities, compared with those whohad experienced little or no adverse reaction. Results from
the study by Goutham et al. [22] also suggested that lym-
phocytes from the patients before radiotherapy had a
higher residual level of fluorescence of γ-H2AX at later
times (24 h) after in vitro irradiation with 2 Gy, more so
in patients who developed severe OM. These results indi-
cate that patients with severe OM are more likely to ex-
hibit DNA repair deficiencies. Therapy-related factors that
may have an important bearing on the development of
mucositis, such as the use of chemotherapy and the irradi-
ation dose to the oral cavity, were not taken into account
as confounding factors in these studies [14,22]. In the
present study, the related parameters from DVH with re-
spect to oral cavity and mucosa, including Dmax, Dmean,
and V30, were measured and found to be similar between
H2AX













Figure 3 ROC curve of residual γ-H2AX fluorescence 24 h post-
irradiation for determining the grades of OM. Receiver Operating
Characteristic (ROC) analysis was performed by SPSS software and
cutoff value was determined based on Youden index. The ordinate
represents the true positive rate, the abscissa represents the false
positive rate. The area under the curve (AUC) was used to assess the
predictive value of γ-H2AX.
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the differences between the dose to and volume of the oral
mucosa did not account for the differences between the
patients with severe and mild OM. Moreover, despite the
different proportion of the patients with severe (8/10) and
mild (9/15) OM undergoing chemoradiotherapy, there
were no differences in treatment regime between patients




























Figure 4 The relationship of relative fluorescence of γ-H2AX
and OM response to radiotherapy in vivo. Blood samples were
collected from patients before radiotherapy (T0), 1 hour after the
fourth fraction of radiotherapy (T1), and 1 hour after the last fraction
of radiotherapy (T2) and the induction of γ-H2AX was assessed using
a FACS-based assay.these confounding factors (concurrent chemo, dose to,
and volume of the oral mucosa) were eliminated. How-
ever, the absence of the influence of concurrent chemo-
therapy, dose to, and volume of the oral mucosa on OM
in our study may be due to the small sample size, a limita-
tion of this study. In our analyses, the level of γ-H2AX-
associated fluorescence at 24 h post-irradiation was a
major contributor to the differences in the severity of
acute OM. Therefore, along with that of other reports,
our data indicated that the patients with severe OM had a
reduced capacity for DNA repair.
ROC analysis was further used to confirm the predictive
value of γ-H2AX expression, and the relative fluorescence
intensity of γ-H2AX (0.965) at 24 h post-irradiation was
the optimal cutoff value, with an AUC value close to
0.8 and sensitivity, specificity, and positive and negative
predictive values being 100%, 53.8%, 62.5%, and 100%, re-
spectively. These data indicate that the H2AX expression-
based method used for predicting OM had fair coverage
of the whole cohort and that HNC patients with relative
fluorescence intensities <0.96 after in vitro irradiation
would be highly likely to experience mild mucositis. The
relatively lower value for the specificity and positive pre-
dictive value with the γ-H2AX expression-based approach
may be a result of pharmaceutical modifiers and the lower
irradiation doses applied to two of the patients (with non-
hodgkin’s lymphoma) in our study.
To our knowledge, there are no previous reports of
clinical data focused on the detection and predictive role
of γ-H2AX in radiotherapy-induced OM, using both
in vivo and in vitro assays. Measurement of the accumu-
lation of DNA damage with the γ-H2AX-based assay has
been demonstrated to enable identification of minor im-
pairments in the DSB-repair capacity, which could not
be detected after single-dose irradiation in a preclinical
murine model [23]. In our study, although higher levels
of γ-H2AX were observed when the patients received a
higher dose of irradiation, indicating that the γ-H2AX
assay reflected the accumulation of incomplete repair of
sublethal damage, the enhancements of γ-H2AX expres-
sion on the fourth and last days after fractionated irradi-
ation were not statistically different between the patients
with mild and severe OM. The lack of differences be-
tween the two groups should not be seen as a failing of
the role of DNA damage accumulation, since there are
many factors involved in the in vivo analysis of γ-H2AX
expression, such as the mixture of irradiated and non-
irradiated blood lymphocytes in the blood samples,
which may confound the analysis. Other complicating
factors include the continuous exchange of lymphocytes
between blood and tissues and elimination of highly
damaged lymphocytes from blood [24]. Our results prove
that the detection of γ-H2AX accumulation induced by ir-
radiation can be used to predict the incidence and severity
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in vitro analysis needs to be performed before radiother-
apy with higher doses and over a longer observation
period. In conclusion, our data support the further devel-
opment of the H2AX-based method as a rapid and con-
venient to identify patients with higher risk of developing
severe OM during radiotherapy.
Although we have observed a correlation between γ-
H2AX induction and the grade of OM prior to radio-
therapy, other studies have not demonstrated such a
relationship [15,25]. The discrepancies in results among
studies may be primarily due to technical differences in
the methodologies implemented, the endpoints, and differ-
ent clinicopathological characteristics of the study popula-
tions. Immunoflurorescence-based microscopic analysis of
γ-H2AX is one of the methods for detection of DNA dam-
age after irradiation. However, manual counting used in
such microscopic analysis may be less accurate, especially
in samples with a greater number of foci, which overlap or
coalescence, such as those observed at dose ranges >2 Gy
[26]. Flow cytometry is an objective and rapid method for
the detection of γ-H2AX signal intensity [14]. These qual-
ities make flow cytometry more attractive for use in the
detection and quantification of γ-H2AX intensity in clin-
ical samples.
In addition to the application of γ-H2AX-based ap-
proaches for the prediction of acute normal tissue damage,
some authors also investigated the role of the γ-H2AX in
the prediction of late normal tissue toxicities. However,
those studies failed to demonstrate a relationship between
the number or intensity of γ-H2AX foci and late radiation
sensitivity [27,28]. The lack of correlation may be ex-
plained by the fact that other factors, in addition to DNA
repair mechanisms, such as fibrotic and inflammatory pro-
cesses, play an important role in the induction of late ad-
verse effects.
Conclusion
In conclusion, our data demonstrate that the H2AX-based
method is suitable for application in a clinical setting.
Flow cytometric analysis of γ-H2AX fluorescence allowed
assessment of DNA damage and DSB repair capacity in
individual HNC patients after irradiation. The dynamic
changes in γ-H2AX fluorescence were evident at higher
doses of irradiation and over longer periods of time after
in vitro irradiation. However, the limited number of pa-
tients is a significant limitation of our study, and these ob-
servation need to be extended and confirmed in a larger
cohort to thoroughly address the utility of the H2AX
expression-based approach in predicting the severity of
OM in HNC patients undergoing radiotherapy.
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